Effect of oral treatment with the essential oil from chenopodium ambrosioides against cutaneous Leishmaniasis in BALB/c Mice, caused by leishmania amazonensis

Forschende Komplementarmedizin

Volumn 16, Issue 5, 2009, Pages 334-338

  Monzote, Lianet ^a   García, Marley ^a   Montalvo, Ana Margarita ^a   Linares, Ramón ^a   Scull, Ramón ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Institute of Pharmacy and Food   (Cuba)

Author keywords

BALB c mice; Chenopodium ambrosioides; Essential oil; Leishmania amazonensis; Therapeutic effect

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; CHENOPODIUM AMBROSIOIDES OIL; ESSENTIAL OIL; MEGLUMINE ANTIMONATE; PENTAMIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHENOPODIUM AMBROSIOIDES; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; LEISHMANIA; MOUSE; NONHUMAN; SKIN LEISHMANIASIS; TREATMENT DURATION;

ANIMALS; ANTIPROTOZOAL AGENTS; CHENOPODIUM AMBROSIOIDES; FEMALE; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; OILS, VOLATILE; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 70449427100     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000237741     Document Type: Article

References (31)

1. Koehn FE, Carter GT: The evolving role of natural products in drug discovery. Nature 2005;4:206-220.
2. Chan MJ, Peña LM: Plant natural products with leishmanicidal activity. Nat Prod Reports 2001;18: 674-688.
3. Harvey AL: Natural products as a screening resource. Curr Opin Chem Biol 2007;11:480-484.
4. Newmann DJ, Cragg GM, Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003;66:1022-1037.
5. Nascimento F, Cruz G, Pereira PV, Maciel M, Silva L, Azevedo AP: Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides treatment. Life Sci 2006;78:2650-2653.
6. Ahmed AA: Highly oxygenated monoterpenes from Chenopodium ambrosioides. J Nat Prod 2000;63: 989-991.
7. Pardo M, Blanco E, Morales R: Plants known as té in Spain: an ethno-pharmaco-botanical review. J Ethnopharmacol 2005;98:1-19.
8. Mac Donald D, VanCrey K, Harrison P, Rangachari PK, Rosenfeld J, Warren C: Ascaridole-less infusions of Chenopodium ambrosioides contain a nematocide(s) that is(are) not toxic to mammalian smooth muscle. J Ethnopharmacol 2004;92:215-221.
9. Gadano AB, Gurni AA, Carballo MA: Argentine folk medicine: genotoxic effects of Chenopodiaceae family. J Ethnopharmacol 2006;103:246-251.
10. Lall N, Meyer JJ: In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. J Ethnopharmacol 1999;66:347-354.
11. Montes-Belmont R, Carvajal M: Control of Aspergillus flavus in maize with plant essential oils and their components. J Food Protect 1998;61:616-619.
12. Pollack Y, Segal R, Golenser J: The effect of ascaridole on the in vitro development of Plasmodium falciparum. Parasitol Res 1990;76:570-572. (Pubitemid 20270775)
13. Kiuchi F, Itano Y, Uchiyama N, Honda G, Tsubouchi A, Nakajima-Shimada J: Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J Nat Prod 2002;65:509-512.
14. Monzote L, Sariego I, Montalvo AM, Garrido N, Scull R, Abreu J: Propiedades antiprotozoarias de aceites esenciales extraídos de plantas cubanas. Rev Cub Med Trop 2004;56:230-233.
15. Giove NRA: Traditional medicine in the treatment of enteroparasitosis. Rev Gastroenterol Peru 1996; 16:197-202.
16. Morsy TA, Shoukry A, Mazyad SA, Makled KM: The effect of the volatile oils of Chenopodium ambrosioides and Thymus vulgaris against the larvae of Lucilia sericata (Meigen). J Egypt Soc Parasitol 1998;28:503-510.
17. Franca F, Lago EL, Marsden PD: Plant used in the treatment of leishmanial ulcers due to Leishmania (Vianna) braziliensis in an endemic area of Bahia, Brazil. Rev Soc Bras Med Trop 1996;29:229-232.
18. Patrício FJ, Costa GC, Pereira PV, Aragão-Filho WC, Sousa SM, Frazão JB, et al: Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis. J Ethnopharmacol 2007;115:313-319.
19. Monzote L, Montalvo AM, Scull R, Miranda M, Abreu J: Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study. Biomed Pharmacother 2007;61:148-153.
20. Monzote L, Montalvo AM, Almanonni AS, Scull R, Miranda M, Abreu J: Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotherapy 2006;52:130-136.
21. Buffet PA, Sulahian A, Garin YJF, Nassar N, Derouin F: Culture microtitration a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 1995;39: 2167-2168.
22. Murray HW, Berman JD, Davies CR, Saraiva NG: Advances in leishmaniasis. Lancet 2005;366:1561-1577.
23. Garcez LM, Goto H, Ramos PK, Briguido MC, Gomes PAF, Souza RA: Leishmania (Leishmania) amazonensis-induced cutaneous leishmaniasis in the primate Cebus apella: a model for vaccine trials. Int J Parasitol 2002;32:1755-1764.
24. Volpini AC, Passos V, Olivera GC, Romanha AJ: PCR-RFLP to identify Leishmania (Vianna) braziliensis and L. (Leishmania) amazonensis causing American cutaneous leishmaniasis. Acta Tropica 2004;90:31-37.
25. Nakayama H, Loiseau PM, Bories C, Torres S, Schinini A, Serna E, et al: Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 2005;49:4950-4956.
26. Al-Abdely HM, Graybill JR, Loebenberg D, Melby PC: Efficacy of the triazole SCH56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 1999;43:2910-2914.
27. Alves LV, Temporal RM, Cysne-Finkelstein L, Leon LL: Efficacy of a diarylheptanoid derivative against Leishmania amazonensis. Mem Inst Oswaldo Cruz 2003;98:553-555.
28. Mishra J, Saxena A, Singh S: Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 2007;14:1153-1169.
29. Donkers RL, Workentin MS: Kinetics of dissociative electron transfer to ascaridole and dyhydroascaridole- model bicyclic endoperoxides of biological relevance. Chemistry 2001;7:4012-4020.
30. Cruz GV, Pereira PV, Patrício FJ, Costa GC, Sousa SM, Frazão JB, et al: Increase of cellular recruitment, phagocytosis ability and nitric oxide production induced by hydroalcoholic extract from Chenopodium ambrosioides leaves. J Ethnopharmacol 2007;111:148-154.
31. Fournet A, Ferreira ME, Rojas A, Torres S, Fuentes S, Nakayama H: In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob Agents Chemother 1996;40:2447-2451.